series-b
Stage
1
Investors
About
Axial Therapeutics develops microbiome-based therapeutics for neurological and gastrointestinal disorders.
Explore Axial Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.